Tag: Pharmaceutical industry news

This morning, Praxis Precision Medicine announced that an independent data monitoring committee recommended discontinuing a Phase 3 study involving its experimental treatment for essential tremors. The analysis indicated that the drug was unlikely to...

Title: Weight Loss Drug Pricing Strategies and Legislative Impact in the Pharmaceutical Industry As we approach the end of another work week, it's time to look forward to weekend plans and relaxation. Whether you're enjoying...

Good morning, this is Jonathan Wosen, reporting on the latest news in the biotech and life sciences world. The FDA has recently approved a new treatment for a rare soft tissue cancer. This cutting-edge...

As the week comes to a close, many are looking forward to weekend plans. Whether it's enjoying the outdoors, planning a holiday break, or connecting with loved ones, there are plenty of ways to...

Good morning and welcome to a new week of work. We hope you had a refreshing weekend because now it's time to get back to the usual routine of online meetings, phone calls, and...

Bernie Sanders, the U.S. Senate health committee chair, has taken a stand against major pharmacy benefit managers in an effort to lower the prices of Novo Nordisk's popular diabetes and obesity treatments, Ozempic and...

As the week comes to an end, it's time to start thinking about weekend plans. Whether it's tidying up, taking a trip to see a college campus, or catching up on reading, there are...

Hello, everyone! It's great to be here with you today. We hope you're all doing well and ready to dive into some interesting news. Today, we have some updates on Novo Nordisk and Amgen...

Good day to you! The sun is shining, the birds are singing, and the Pharmalot campus is buzzing with activity. We're starting our day with a delicious cup of hot buttery rum coffee, sweetened...

The National Institutes of Health (NIH) technology transfer offices have hit a roadblock, halting the filing of new patent applications and restricting the licensing of existing ones for the past five weeks, as reported...

U.K. Restricts Lilly's Obesity Drug to Those in Greatest Need In a move to adapt to the rising demand for obesity treatment, the U.K. announced that it will be offering Eli Lilly's weight loss drug,...

Well, hey there, folks! How's it going on this fine day? We're hanging in there, thank you very much, especially since we've hit the midpoint of the week. I mean, we've made it this...